Europe Cancer Cachexia Market - 2022-2030
Description
Europe Cancer Cachexia Market Overview:
The Europe Cancer Cachexia Market was valued at US$ 618.75 million in 2022 and is anticipated to reach US$ 897.58 million by 2030, at a CAGR of 0.048 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Europe Cancer Cachexia Market.
This report delivers a comprehensive overview of the Europe Cancer Cachexia Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Cancer Cachexia Market. The Europe Cancer Cachexia Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
Europe Cancer Cachexia Market Scope:
By Therapeutics
• Corticosteroids
• Cannabinoids (Dronabinol)
• Anabolic Steroids
• Cytokine Inhibitors
• Others
By Mechanism
• Appetite Stimulator
• Weight Loss Stabilizers
• Others
By Distribution Channel
• Hospital Stores
• Retail Pharmacy Stores
• Online Pharmacy
Key Players
• Actimed Therapeutics Ltd.
• Aphios Corporation
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Helsinn Group
• Merck & Co. Inc.
• Fresenius Kabi AG
• NGM Biopharmaceuticals
• Aveo Oncology
• AAVogen Inc.(LIST NOT EXHAUSTIVE)
Major Highlights
This report delivers a comprehensive overview of the Europe Cancer Cachexia Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Cancer Cachexia Market. The Europe Cancer Cachexia Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
The Europe Cancer Cachexia Market was valued at US$ 618.75 million in 2022 and is anticipated to reach US$ 897.58 million by 2030, at a CAGR of 0.048 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Europe Cancer Cachexia Market.
This report delivers a comprehensive overview of the Europe Cancer Cachexia Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Cancer Cachexia Market. The Europe Cancer Cachexia Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
Europe Cancer Cachexia Market Scope:
By Therapeutics
• Corticosteroids
• Cannabinoids (Dronabinol)
• Anabolic Steroids
• Cytokine Inhibitors
• Others
By Mechanism
• Appetite Stimulator
• Weight Loss Stabilizers
• Others
By Distribution Channel
• Hospital Stores
• Retail Pharmacy Stores
• Online Pharmacy
Key Players
• Actimed Therapeutics Ltd.
• Aphios Corporation
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Helsinn Group
• Merck & Co. Inc.
• Fresenius Kabi AG
• NGM Biopharmaceuticals
• Aveo Oncology
• AAVogen Inc.(LIST NOT EXHAUSTIVE)
Major Highlights
This report delivers a comprehensive overview of the Europe Cancer Cachexia Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Cancer Cachexia Market. The Europe Cancer Cachexia Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
210 Pages
- 1. Market Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Market Definition and Overview
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing incidences of cancer cachexia
- 4.1.1.2. Government fundings
- 4.1.1.3. Increasing clinical trials and research activities in Europe
- 4.1.2. Restraints:
- 4.1.2.1. High cost of treatment
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Supply Chain Analysis
- 5.3. Regulatory Analysis
- 5.4. Pipeline Analysis
- 5.5. Pricing Analysis
- 6. COVID-19 Analysis
- 6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
- 6.2. Pricing Dynamics Amid Covid-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During the Pandemic
- 6.5. Manufacturer’s Strategic Initiatives
- 6.6. Conclusion
- 7. By Therapeutics
- 7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 7.1.2. Market Attractiveness Index, By Therapeutics
- 7.2. Corticosteroids *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
- 7.3. Cannabinoids (Dronabinol)
- 7.4. Anabolic Steroids
- 7.5. Cytokine Inhibitors
- 7.6. Others
- 8. By Mechanism
- 8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 8.1.2. Market Attractiveness Index, By Mechanism
- 8.2. Appetite Stimulator*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
- 8.3. Weight Loss Stabilizers
- 8.4. Others
- 9. By Distribution Channel
- 9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
- 9.2. Hospital Stores*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
- 9.3. Retail Pharmacy Stores
- 9.4. Online Pharmacy
- 10. By Country
- 10.1. Introduction
- 10.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
- 10.1.2. Market Attractiveness Index, By Country
- 10.2. Germany
- 10.2.1. Introduction
- 10.2.2. Key Country-Specific Dynamics
- 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3. The U.K.
- 10.3.1. Introduction
- 10.3.2. Key Country-Specific Dynamics
- 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4. France
- 10.4.1. Introduction
- 10.4.2. Key Country-Specific Dynamics
- 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5. Italy
- 10.5.1. Introduction
- 10.5.2. Key Country-Specific Dynamics
- 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.6. Spain
- 10.6.1. Introduction
- 10.6.2. Key Country-Specific Dynamics
- 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.7. Rest of Europe
- 10.7.1. Introduction
- 10.7.2. Key Country-Specific Dynamics
- 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
- 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mechanism
- 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11. Competitive Landscape
- 11.1. Key Developments and Strategies
- 11.2. Merger and Acquisitions
- 11.3. Product Benchmarking
- 12. Company Profiles
- 12.1. Actimed Therapeutics Ltd.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Key Highlights
- 12.1.4. Financial Overview
- 12.2. Aphios Corporation
- 12.3. Bristol-Myers Squibb Company
- 12.4. Pfizer Inc.
- 12.5. Helsinn Group
- 12.6. Merck & Co. Inc.
- 12.7. Fresenius Kabi AG
- 12.8. NGM Biopharmaceuticals
- 12.9. Aveo Oncology
- 12.10. AAVogen Inc.(*LIST NOT EXHAUSTIVE)
- 13. DataM Intelligence
- 13.1. Appendix
- 13.2. About Us and Services
- 13.3. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
